SR

Satendra Rajbhar

Active Director Director DIN 07702626
DIN 07702626 First appointment Feb 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value •••• Premium profile

About Satendra Rajbhar

Data last updated:

Satendra Rajbhar is a Director at Zencon Pharma Private Limited (since 2017). The company operates in Pharma. Zencon Pharma Private Limited reported revenue of ₹1.1 Lakh (FY 2018).

DIN 07702626
Primary Designation Director
Industry Pharma
First Appointment 07 Feb 2017
Oldest Company Age 9 yrs
Largest company Zencon Pharma Private Limited · ₹1.1 Lakh (FY 2018)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zencon Pharma Private Limited U93090MH2017PTC290853
Director07 Feb 20172017₹1.1 Lakh (FY 2018)Active

Board colleagues of Satendra Rajbhar

NameDINCompanyDesignation
Brijesh Rajbhar07700209Zencon Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zencon Pharma Private Limited
Premium access

Shareholding and investment profile for Satendra Rajbhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satendra Rajbhar

Satendra Rajbhar currently holds 1 directorship: Zencon Pharma Private Limited (Director, since 07 Feb 2017, revenue ₹1.1 Lakh (FY 2018)).

Satendra Rajbhar was first appointed on 07 Feb 2017 as Director at Zencon Pharma Private Limited.

The current boards of Satendra Rajbhar's companies include Brijesh Rajbhar (Zencon Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available